BioCardia said the U.S. Food and Drug Administration confirmed that its ongoing CardiAMP Heart Failure II study could support ...

BioCardia Inc. (NASDAQ:BCDA) shares surged 26.2% in premarket trading on Friday after the company announced that the U.S.

Participants exposed critical gaps in the diagnosis, treatment, and coordination of care for patients with heart failure with preserved ejection fraction and charted a path forward.

Early report on modular BioVAT patches in advanced stage C or D disease ...

Finerenone also reduced albuminuria at month 12 by 42% and lowered the risk of kidney failure or an eGFR decline of 40% or ...

Serial KCCQ-TSS decline emerged as the most prominent pre-event signal for sudden death, contrasting with improving symptoms ...

New science found menopause changes the heart at a genetic level and HRT may offer more protection than previously thought.

Bunkerhill Health’s FDA-cleared ECG-EF algorithm for the detection of reduced ejection fraction becomes the first cleared AI-ECG algorithm available through MyoVista Insights, advancing HeartSciences’ ...

Heart disease kills more American women than any other condition, and new research suggests scientists have been underestimating what menopause actually does to the cardiovascular system. The finding ...

Goldman Sachs 47th Annual Global Healthcare Conference 2026 June 8, 2026 4:00 PM EDTCompany ParticipantsAlexander Cumbo ...

Pharmacists Corewell Health transforming heart failure care by accelerating medication optimization and improving patient outcomes in Michigan.